Drug class in one race
B7-H3 drugs for Non-Small Cell Lung Cancer
7 tracked B7-H3 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the B7-H3 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
2 Phase 31 Phase 22 Phase 1/21 Phase 11 preclinical / unstaged